Article Menu
Need Help?
No Article Versions Notes Found
Cite
Lapmag, A.; Lertsinudom, S.; Chaiyakam, A.; Sawanyawisuth, K.; Tiamkao, S.; Khon Kaen University, o.b.o.I.E.R.G. Clinical Outcomes of Intravenous Levetiracetam Treatment in Patients with Renal Impairment. Neurol. Int. 2018, 10, 7469. https://doi.org/10.4081/ni.2018.7469
Lapmag A, Lertsinudom S, Chaiyakam A, Sawanyawisuth K, Tiamkao S, Khon Kaen University oboIERG. Clinical Outcomes of Intravenous Levetiracetam Treatment in Patients with Renal Impairment. Neurology International. 2018; 10(2):7469. https://doi.org/10.4081/ni.2018.7469
Chicago/Turabian StyleLapmag, Anyamanee, Sunee Lertsinudom, Aporanee Chaiyakam, Kittisak Sawanyawisuth, Somsak Tiamkao, and on behalf of Integrated Epilepsy Research Group, Khon Kaen University. 2018. "Clinical Outcomes of Intravenous Levetiracetam Treatment in Patients with Renal Impairment" Neurology International 10, no. 2: 7469. https://doi.org/10.4081/ni.2018.7469
APA StyleLapmag, A., Lertsinudom, S., Chaiyakam, A., Sawanyawisuth, K., Tiamkao, S., & Khon Kaen University, o. b. o. I. E. R. G. (2018). Clinical Outcomes of Intravenous Levetiracetam Treatment in Patients with Renal Impairment. Neurology International, 10(2), 7469. https://doi.org/10.4081/ni.2018.7469
